focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuantum Pharma Share News (QP.)

  • There is currently no data for QP.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quantum Pharma launches third product from its Mucodis range of treatments

Mon, 11th Jul 2016 15:47

(ShareCast News) - Quantum Pharma launched the third product of its Mucodis range for the treatment of some of the side effects suffered by patients undergoing cancer treatment.Mucodis dermal spray, which reached markets on Monday, was targetted at treating radiation-induced dermatitis, a condition which most radiotherapy patients experienced, the company said.Andrew Scaife, Chief Executive of Quantum Pharma Plc, commented: " [...] There is a clear unmet need for this type of relief and we are confident that our products will have a significant effect on improving the patient's quality of life."The severity of the skin condition could range from moderate to a severe type-2 skin reaction for 85.0% of the patients under treatment and was characterised by disorders such as inflammation to necrosis or peeling.Every year, 352,000 patients in the UK were diagnosed with cancer, Quantum Pharma said in a statement.The Mucodis range was meant to provide the NHS with prescribable products to address a number of the side effects associated with cancer treatments including mucositis, radiation-induced dermatitis, vulvovaginitis and proctitis, according to the company.The launch of Mucodis dermal spray marked another positive step forward for Quantum, analysts at N+1 Singer said in a research note sent to clients."Evidence is building that the pipeline is now delivering and we expect further similar launches in due course. This should in turn result in a step change in profitability and cash generation and lead to a substantial re-rating of the shares."As of 15:58 BST shares in Quantum Pharma were unchanged at 67.0p, giving the pharma firm a market capitalisation of £83.75m.
More News
20 Oct 2016 11:35

Quantum Pharma conditionally raises £15m in accelerated bookbuild

(ShareCast News) - Quantum Pharma confirms its accelerated bookbuild to raise up to £15m has closed successfully, subject to the passing of certain resolutions by shareholders at the company's annual meeting. The company, which noted that it continued to trade in line, believed net proceeds would re

Read more
20 Oct 2016 07:41

Quantum Pharma Raises GBP15 Million To Pay Down Debt (ALLISS)

Read more
4 Oct 2016 09:10

Quantum Pharma's shares plummet as it expects to perform below expectations in H2

(ShareCast News) - Shares in AIM-listed drug manufacturer Quantum Pharma plunged nearly 50% on Tuesday morning as it said it expects the performance in the second half of the year to be "materially below market expectations" although it anticipates "strong" growth. Chief financial officer and acting

Read more
31 Aug 2016 11:48

Quantum Pharma looks to meet FY market expectations

(ShareCast News) - Quantum Pharma has made good progress during its first half, in line with management views, and anticipates meeting market expectations for the full year. "As previously indicated, the group's performance for the year is second-half weighted and will be dependent on the level of s

Read more
10 Aug 2016 07:37

Quantum Pharma's Colonis Launches Peptic Ulcer Treatment

Read more
5 Aug 2016 12:03

Quantum Pharma completes Mucodis range with vaginal cream

(ShareCast News) - Niche pharmaceutical developer Quantum Pharma announced on Friday that its subsidiary Colonis has launched Mucodis vaginal cream. The AIM-traded company said the cream is part of the Mucodis range of in-licensed patented medical devices, which focus on treating some of the side ef

Read more
26 Jul 2016 12:00

Quantum Pharma launches Mucodis Rectal Gel

(ShareCast News) - Quantum Pharma said Colonis has launched its Mucodis Rectal Gel for preventing and treating rectal mucositis, a common side effect of chemotherapy and radiotherapy in cancer patients. Mucositis is a condition characterised by pain and inflammation of the body's mucous membranes wh

Read more
26 Jul 2016 09:35

Quantum Pharma Launches Mucodies Rectal Gel Product

Read more
12 Jul 2016 13:41

Quantum Pharma CEO Scaife steps down, trading in line

(ShareCast News) - Quantum Pharma chief executive Andrew Scaife has stepped down after seven years but is leaving the company with current trading running in line with management expectations. Scaife has decided to leave the Newcastle-upon-Tyne company due to family reasons but has agreed to stay un

Read more
12 Jul 2016 07:31

Quantum Pharma CEO Resigns As First-Half Trading Meets Expectations

Read more
11 Jul 2016 07:44

Quantum Pharma's Colonis Launches Mucodis Dermal Spray

Read more
5 Jul 2016 15:05

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Jun 2016 07:26

Quantum Pharma Set To Commercialise Biodose Connect Device

Read more
10 May 2016 07:27

Quantum Pharma Profit Surges And Dividend Hiked After Strong Year

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.